サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390563

ウシ胎児血清市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Fetal Bovine Serum Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 148 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ウシ胎児血清市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界のウシ胎児血清市場規模は2022年に9億4,800万米ドルに達しました。今後、IMARC Groupは、市場は2028年までに13億3,330万米ドルに達し、2022年から2028年の間に5.85%の成長率（CAGR）を示すと予測しています。

ウシ胎児血清（FBS）は動物細胞培養培地の主要成分で、牛の胎児から得られます。FBSには、細胞の成長に不可欠ないくつかの栄養因子と高分子因子が含まれています。これに加えて、アミノ酸、糖、脂質、ホルモン、低ガンマグロブリン含量も含んでいます。その結果、必須栄養素の供給や真核細胞培養における細胞の生存と増殖の促進など、さまざまな用途に広く利用されています。また、研究、製造、バイオ医薬品、ヒトおよび動物用ワクチンの管理にも使用されています。

ウシ胎児血清市場の動向：

FBSは、コロナウイルス病（COVID-19）による急性および慢性の肺障害を患う患者を治療するための幹細胞の生成に応用されています。さらに、FBSには成長因子や抗体が含まれており、細胞を分裂、成長、進化させるために生かすことができるため、様々な科学研究において極めて重要な役割を果たしています。このことは、新規バイオ医薬品を導入するための政府機関や民間機関による資金提供の増加による研究開発（R&D）活動の著しい成長とともに、世界のFBSの需要を刺激しています。さらに、急性および慢性疾患の有病率の増加を背景としたバイオ医薬品に対する需要の高まりも、市場の成長に寄与しています。これとは別に、核家族化と所得水準の上昇という新たな動向は、ペットの所有と人間化にプラスの影響を与えており、その結果、コンパニオンアニマルの導入が世界中で増加しています。このことは、動物由来製品の消費量の増加とともに、世界中の感染症予防のための動物用診断薬およびワクチンにおけるFBSの必要性を煽ると予想されます。

本レポートで扱う主な質問

  • 2022年の世界のウシ胎児血清市場規模は？
  • 2023-2028年の世界のウシ胎児血清市場の予想成長率は？
  • COVID-19が世界のウシ胎児血清市場に与えた影響は？
  • 世界のウシ胎児血清市場を牽引する主要因は？
  • 世界のウシ胎児血清市場の製品別区分は？
  • 用途別のウシ胎児血清世界市場内訳は？
  • エンドユーザー別のウシ胎児血清世界市場内訳は？
  • 世界のウシ胎児血清市場における主要地域は？
  • 世界のウシ胎児血清市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のウシ胎児血清市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 活性炭処理
    • 市場動向
    • 市場予測
  • クロマトグラフィー
    • 市場動向
    • 市場予測
  • 透析ウシ胎児血清
    • 市場動向
    • 市場予測
  • エクソソーム除去
    • 市場動向
    • 市場予測
  • 幹細胞
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • バイオ医薬品
    • 市場動向
    • 市場予測
  • 細胞培養
    • 市場動向
    • 市場予測
  • ヒトと動物のワクチン生産
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • バイオ・製薬企業
    • 市場動向
    • 市場予測
  • 学術機関
    • 市場動向
    • 市場予測
  • 研究機関
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Atlas Biologicals Inc.
    • Biological Industries（Sartorius AG）
    • Bio-Techne Corporation
    • BioWest
    • Bovogen Biologicals Pty Ltd.
    • General Electric Company
    • HiMedia Laboratories
    • Merck KGaA
    • PAN-Biotech
    • Rocky Mountain Biologicals
    • TCS Biosciences Ltd
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Fetal Bovine Serum Market: Major Drivers and Challenges
  • Figure 2: Global: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Fetal Bovine Serum Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Fetal Bovine Serum Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Fetal Bovine Serum Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Fetal Bovine Serum Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Fetal Bovine Serum (Charcoal Stripped) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Fetal Bovine Serum (Charcoal Stripped) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Fetal Bovine Serum (Chromatographic) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Fetal Bovine Serum (Chromatographic) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Fetal Bovine Serum (Dialyzed Fetal Bovine Serum) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Fetal Bovine Serum (Dialyzed Fetal Bovine Serum) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Fetal Bovine Serum (Exosome Depleted) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Fetal Bovine Serum (Exosome Depleted) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Fetal Bovine Serum (Stem Cell) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Fetal Bovine Serum (Stem Cell) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Fetal Bovine Serum (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Fetal Bovine Serum (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Fetal Bovine Serum (Biopharmaceuticals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Fetal Bovine Serum (Biopharmaceuticals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Fetal Bovine Serum (Cell Culture) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Fetal Bovine Serum (Cell Culture) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Fetal Bovine Serum (Human and Animal Vaccine Production) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Fetal Bovine Serum (Human and Animal Vaccine Production) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Fetal Bovine Serum (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Fetal Bovine Serum (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Fetal Bovine Serum (Biotechnology and Pharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Fetal Bovine Serum (Biotechnology and Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Fetal Bovine Serum (Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Fetal Bovine Serum (Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Fetal Bovine Serum (Research Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Fetal Bovine Serum (Research Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Fetal Bovine Serum (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Fetal Bovine Serum (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: North America: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: North America: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: United States: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: United States: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Canada: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Canada: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Asia-Pacific: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Asia-Pacific: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: China: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: China: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Japan: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Japan: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: India: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: India: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: South Korea: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: South Korea: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Australia: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Australia: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Indonesia: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Indonesia: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Others: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Others: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Europe: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Europe: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Germany: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Germany: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: France: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: France: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: United Kingdom: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: United Kingdom: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Italy: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Italy: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Spain: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Spain: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Russia: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Russia: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Latin America: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Latin America: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Brazil: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Brazil: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Mexico: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Mexico: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Others: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Others: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Middle East and Africa: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Middle East and Africa: Fetal Bovine Serum Market: Breakup by Country (in %), 2022
  • Figure 84: Middle East and Africa: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Global: Fetal Bovine Serum Industry: SWOT Analysis
  • Figure 86: Global: Fetal Bovine Serum Industry: Value Chain Analysis
  • Figure 87: Global: Fetal Bovine Serum Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Fetal Bovine Serum Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Fetal Bovine Serum Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Fetal Bovine Serum Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Fetal Bovine Serum Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Fetal Bovine Serum Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Fetal Bovine Serum Market: Competitive Structure
  • Table 7: Global: Fetal Bovine Serum Market: Key Players
目次
Product Code: SR112023A4345

Abstract

The global fetal bovine serum market size reached US$ 948.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,333.3 Million by 2028, exhibiting a growth rate (CAGR) of 5.85% during 2022-2028.

Fetal bovine serum (FBS) is a major component of animal cell culture media, which is obtained from bovine fetuses of cows. It has several nutritional and macromolecular factors that are essential for cell growth. Besides this, it also comprises amino acids, sugars, lipids, hormones, and low gamma globulin content. As a result, it is widely utilized in a range of applications, such as providing essential nutrients and facilitating cell survival and proliferation in eukaryotic cell culture. It is also used in research, manufacturing, biotech drugs, and controlling human and veterinary vaccines.

Fetal Bovine Serum Market Trends:

FBS finds application in generating stem cells for treating patients suffering from acute and chronic lung damage due to coronavirus disease (COVID-19). In addition, as it contains growth factors and antibodies that can be utilized in laboratories to keep cells alive for dividing, growing, and evolving, it plays a pivotal role in various scientific research. This, along with significant growth in the research and development (R&D) activities on account of increasing funding by governing and private agencies to introduce novel biopharmaceuticals, is catalyzing the demand for FBS worldwide. Furthermore, the escalating demand for biopharma products on account of the growing prevalence of acute and chronic diseases is contributing to the growth of the market. Apart from this, the emerging trend of nuclear families and inflating income levels are positively influencing pet ownership and humanization, which is resulting in the increasing adoption of companion animals across the globe. This, along with the rising consumption of animal-derived products, is anticipated to fuel the need for FBS in veterinary diagnostics and vaccines to prevent infectious diseases around the world.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global fetal bovine serum market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Charcoal Stripped

Chromatographic

Dialyzed Fetal Bovine Serum

Exosome Depleted

Stem Cell

Others

Breakup by Application:

Biopharmaceuticals

Cell Culture

Human and Animal Vaccine Production

Others

Breakup by End User:

Biotechnology and Pharmaceutical Companies

Academic Institutes

Research Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Atlas Biologicals Inc., Biological Industries (Sartorius AG), Bio-Techne Corporation, BioWest, Bovogen Biologicals Pty Ltd., General Electric Company, HiMedia Laboratories, Merck KGaA, PAN-Biotech, Rocky Mountain Biologicals, TCS Biosciences Ltd and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global fetal bovine serum market in 2022?
  • 2. What is the expected growth rate of the global fetal bovine serum market during 2023-2028?
  • 3. What has been the impact of COVID-19 on the global fetal bovine serum market?
  • 4. What are the key factors driving the global fetal bovine serum market?
  • 5. What is the breakup of the global fetal bovine serum market based on the product?
  • 6. What is the breakup of the global fetal bovine serum market based on the application?
  • 7. What is the breakup of the global fetal bovine serum market based on the end user?
  • 8. What are the key regions in the global fetal bovine serum market?
  • 9. Who are the key players/companies in the global fetal bovine serum market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Fetal Bovine Serum Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Charcoal Stripped
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Chromatographic
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Dialyzed Fetal Bovine Serum
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Exosome Depleted
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Stem Cell
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Biopharmaceuticals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cell Culture
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Human and Animal Vaccine Production
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Biotechnology and Pharmaceutical Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Academic Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research Laboratories
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Atlas Biologicals Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Biological Industries (Sartorius AG)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bio-Techne Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 BioWest
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Bovogen Biologicals Pty Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 General Electric Company
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 HiMedia Laboratories
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 PAN-Biotech
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Rocky Mountain Biologicals
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 TCS Biosciences Ltd
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis